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Abstract.  The expression of tissue transglutaminase  in 
skeletal tissues is strictly regulated and correlates with 
chondrocyte differentiation and cartilage calcification 
in endochondral bone formation and in maturation of 
tracheal cartilage (Aeschlimann,  D., A. Wetterwald, 
H. Fleisch, and M.  Paulsson.  1993. J.  Cell Biol. 
120:1461-1470).  We now demonstrate the trans- 
glutaminase reaction product,  the 3,-glutamyl-e-lysine 
cross-link,  in the matrix  of hypertrophic cartilage 
using a novel cross-link specific antibody. Incorpora- 
tion of the synthetic transglutaminase  substrate 
monodansylcadaverine (amine donor) in cultured tra- 
cheal explants reveals enzyme activity in the pericellu- 
lar matrix of hypertrophic chondrocytes in the central, 
calcifying areas of the horseshoe-shaped cartilages. 
One predominant  glutaminyl  substrate (amine accep- 
tor) in the chondrocyte matrix  is osteonectin as re- 
vealed by incorporation of the dansyl label in culture. 
Indeed, nonreducible osteonectin-containing complexes 
of *65, 90, and  175 kD can be extracted from mature 
tracheal cartilage.  In vitro cross-linking of osteonectin 
by tissue transglutaminase  gives similar products of 
,,o90 and  175 kD, indicating that the complexes in car- 
tilage represent osteonectin oligomers.  The demonstra- 
tion of extracellular transglutaminase  activity in 
differentiating cartilage,  i.e.,  cross-linking of osteo- 
nectin in situ,  shows that tissue transglutaminase- 
catalyzed cross-linking  is a physiological mechanism 
for cartilage matrix  stabilization. 
ONG bone development and growth occurs by endochon- 
dral ossification  (Hunziker and  Schenk,  1989; So- 
lursh,  1989).  In  this  process  chondrocytes  pass 
through a series of differentiation  stages in which they rap- 
idly proliferate,  synthesize  matrix  constituents  at high rate 
and become hypertrophic,  before the cartilage  matrix  cal- 
cifies. The calcified matrix is subsequently replaced by bone. 
The differentiating chondrocytes also change their repertoire 
of biosynthetic products and express e.g., collagen  X, os- 
teopontin, and osteonectin (for references  see Aeschlimann 
et al.,  1993).  Rat tracheal  cartilage  undergoes  maturation 
and calcification  in a manner resembling  chondrocyte dif- 
ferentiation  during  endochondral  bone formation  (Aeschli- 
mann et al., 1993), with the exception that matrix calcifica- 
tion is not followed by cartilage resorption,  vascularization, 
and bone formation. 
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We previously reported  that  tissue  transglutaminase  is 
synthesized  and  externalized  by terminally  differentiating 
chondrocytes both in endochondral  bone formation  and in 
maturation  of tracheal cartilage (Aeschlimann et al., 1993). 
The transglutaminase  catalyzes the posttranslational  mod- 
ification of proteins referred to as R-glutamyl-peptide, amine- 
3,-glutamyl transfer reaction (EC 2.3.2.13).  The Ca2+-depen  - 
dent reaction results in the formation of new 3,-amide bonds 
between 3,-carboxamide groups of peptide-bound glutamine 
residues and various  primary amines (for review  see Folk 
and Finlayson,  1977; Lorand and Conrad, 1984). Most com- 
monly,  3,-glutamyl-e-lysine  cross-links  are  formed  in  or 
between proteins  by reaction  with e-amino  groups of pep- 
tide-bound  lysine residues.  Osteonectin  is a potent in vitro 
glutaminyl  substrate  for  tissue  transglutaminase  and  is 
coexpressed with  the  enzyme  in  differentiating  cartilage 
(Aeschlimann  et al.,  1993). It appears  that tissue transglu- 
taminase may function  in cartilage  by cross-linking  matrix 
proteins like osteonectin before mineralization  of the tissue. 
Osteonectin  was  initially  identified  as one of the  most 
abundant  noncollagenous  proteins  in bone (Termine et al., 
1981a; Bolander et al., 1988), but is also widely distributed 
in other tissues, although in lower amounts (Dziadek et al., 
1986;  Mason et al.,  1986;  Stenner  et al.,  1986;  Lankat- 
Buttgereit et al., 1988). It has been implicated in the miner- 
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calcium-binding domains, one of them in the form of an EF- 
hand (Engel et al., 1987; Maurer et al., 1992), and appears 
to have affinity for hydroxy-apatite (Termine et al., 1981b). 
However,  as osteonectin is not bone specific,  this line of 
reasoning is insufficient  to explain all biological functions of 
this protein, and tissue-specific posttranslational modifica- 
tions may modulate some of its functions (Kelm and Mann, 
1991). 
Transglutaminases form a large protein family, with mem- 
bers specialized for protein cross-linking in different  biologi- 
cal systems (Aeschlimann and Paulsson,  1994).  Examples 
are the stabilization of the fibrin clot in hemostasis by the ac- 
tivated plasma transglutaminase, factor XHIa, and the role 
of transglutaminases in  the  process  of physiological cell 
death, e.g., in the formation of the cornified envelope by 
epidermal transglutaminases in keratinocyte terminal dif- 
ferentiation, and in the cross-linking of membrane and cyto- 
skeletal components by tissue transglutaminase in aging of 
erythrocytes (Lorand and Conrad, 1984;  Aeschlimann and 
Paulsson,  1994).  Tissue transglutaminase may also play a 
role in programmed death of other cells since it accumulates 
in the cytoplasm of e.g., hepatocytes undergoing terminal 
differentiation  both in vivo and in vitro (for review see F6sus 
et al., 1991). There is also increasing evidence for the occur- 
rence of tissue transglutaminase-catalyzed reactions outside 
the cell, although the mechanism of enzyme externalization 
remains unclear (Aeschlimann and Paulsson, 1991; Aesch- 
limann et al.,  1993).  This evidence includes the identifica- 
tion of a number of different extracellular matrix proteins as 
specific  glutaminyl substrates (for references see Aeschli- 
mann et al.,  1992;  Aeschlimann and Paulsson,  1994),  the 
demonstration  of tissue  transglutaminase  activity  in  the 
pericellular matrix of cultured hepatocytes and endothelial 
cells (Barsigian et al., 1991, and references therein), and of 
tissue transglutaminase protein in various extracellular ma- 
trices  in  vivo  (Aeschlimann and  Paulsson,  1991; Aesch- 
limann et al.,  1993).  Extracellular tissue transglutaminase 
may play a role in the assembly of the matrix, but also in 
events related to wound healing and excessive  tissue repair 
since active enzyme binds to the extracetlular matrix with 
high affinity after wounding of cells (Upchurch et al., 1991) 
and may modulate matrix production by regulating the con- 
version of latent into active TGF-B (Kojima et al.,  1993). 
The present study concerns the expression of transglu- 
taminase activity during cartilage maturation and the iden- 
tification of substrate proteins in cartilage cross-linked by 
transglutaminases in  situ.  The  preparation  of antibodies 
specific  for the ,y-glutamyl-e-lysine cross-link allowed the 
immunohistochemical analysis of tissues for cross-linking 
by transglutaminases in vivo.  Transglutaminase cross-link- 
ing in cartilage was predominant in the hypertrophic zone of 
long bone growth plate and of maturing trachea. Explant cul- 
ture of rat trachea in the presence of the transglutaminase 
amine donor substrate monodansylcadaverine revealed en- 
zyme activity in the pericellular matrix of the chondrocytes 
in the calcifying  areas. Osteonectin was identified as one pre- 
dominant target protein for cross-linking in this tissue. These 
findings further support the physiological importance of (tis- 
sue) transglutaminase-catalyzed cross-linking in extracellu- 
lar matrices. 
Materials and Methods 
Organ Culture 
Tracheae were prepared under aseptic conditions from rats of defined age, 
cut longitudinally into halves, rinsed extensively with Earle's balanced salt 
solution, and cultured in medium M-199, containing 10% fetal calf serum 
and penicillin (100 U/ml), streptomycin (100/~g/ml), and fungizone (2.5 
/,g/nil). (All cell culture reagents were from GIBCO BRL, Gaithersburg, 
MD.)  The  explants  were  maintained  in  24-well  plates  with  ~0.5  ml 
medium, a volume sufficient to just cover the tissue pieces. The tracheae 
were allowed to adapt to the culture conditions for 4 d with two medium 
changes before pulse-labeling with 0.1 or 0.5 mM of the transglutaminase 
substrate  monodansylcadaverine (N-[5'-aminopentyl]-5-dimethylamino-1- 
naphthalene sulfonamide; Sigma Immunochemicals, St.  Louis,  MO) for 
24 h, followed by a 24-h chase period. Control cultures were treated with 
the substrate analogue dansylamidopentanol (0.1 or 0.5 mM, see below). The 
dansyl compounds were dissolved in 0.1  M HCI and diluted 1:250 in the 
medium. The pH of the medium was readjusted and the concentration of 
either label verified by absorbance measurement at 335 nm. Cell viability 
was verified by pulse-labeling with 40 tzCi/ml  L-[35S]methionine  (1,000 
Ci/mmol, Amersham Corp., Amersham, UK) after treatment with either 
substance. The cultured tracheae were rinsed with Earle's balanced salt so- 
lution before further processing as described below. 
Dansylamidopentanol (N-[5'-hydroxypentyl]-5-dimethylamino-naphtha- 
lene-l-sulfonamide) was synthesized from l-amino-5-pentanol (0.9 g) dis- 
solved in 10 ml ethanol by dropwise addition of  dansylchloride  (I.0 g; Fluka, 
Buchs, Switzerland) dissolved in 8.9 ml ether and 1.1 ml triethylamine with 
stirring for 2 h in the dark. The yellow oil obtained after evaporation of the 
solvent was dissolved in ether and extracted repeatedly with 50 mM HCI. 
The aqueous phases were combined and reextracted with a small volume 
of CHCI3.  After evaporation of the solvent, the yellow gum was dissolved 
in a small volume of 50 mM HC1 and the product precipitated by addition 
of ,'~100 ml 0.2 M ammonium hydrogen carbonate. Dansylamidopentanol 
was allowed to crystallize from this solution at pH 9.0 and 4°C for 3-10 d. 
The pH was readjusted repeatedly. The product was recrystallized from 
0.2 M ammonium hydrogen carbonate giving a final yield of 500-600 mg. 
The purity of the product was verified by TLC (Kieselge160; Merck, Darm- 
stadt, Germany) in acetone and examination under UV light or after iodine 
staining. The identity of the product was confirmed by infrared spectros- 
copy (R-SO2-N:  1150 and 1310 cm  -t, -OH: 3520 cm-t), the absorbance 
spectrum (absmax of fluorophore: 335 nm), and mass spectroscopy (experi- 
mentally determined: Mr  =  336,  M ÷l , 20.88%;  M ÷2, 6.54%; calculated: 
Mr =  336;  M +l,  20.90%;  M +~, 5.03%). 
Protein Reagents 
Tissue transglutaminase was purified from guinea pig liver (Connellan et 
al., 1971). Osteonectin was prepared from young adult rat long bone accord- 
ing to a modification of the procedure established for the human protein by 
Fisher et al. (1987).  A purity of >90% was achieved after two additional 
chromatographic steps,  i.e.,  on hydroxyapatite (Bio-Gel HTP;  Bio-Rad 
Laboratories, Hercules, CA), eluted with a linear gradient of 10-500 mM 
sodium phosphate, pH 6.8, in 7 M urea, and on Mono S (fast protein liquid 
chromatography [FPLC]I; Pharmacia LKB Biotechnology, Inc., Uppsala, 
Sweden), eluted with a linear gradient of 0-0.5 M NaC1 in 20 mM sodium 
acetate, pH 4.8, 7 M urea. The rat osteonectin was finally characterized by 
NH2-terminal sequencing after separation by SDS-PAGE and blotting to 
polyvinylidene difluoride membrane (Immobilon P;  Millipore, Bedford, 
MA) as described (Aeschlimann et al.,  1992).  Native recombinant human 
BM-40/osteonectin (Nischt et al.,  1991) was kindly provided by Dr.  R. 
Timpl (Max-Planck-Institute for Biochemistry, Germany). 
Antisera to guinea pig tissue transglutaminase (Aeschlimann and Pauls- 
son,  1991), rat  osteonectin, and dansylated (hapten) hemocyanin (Aes- 
chlimann et al.,  1993)  were raised in rabbits and affinity  purified when 
needed (Aeschlimann and Paulsson, 1991). A monoclonal antibody against 
collagen type II (CIICI;. Holmdahl et al., 1986) was from the Developmen- 
tal Studies Hybridoma Bank (University of Iowa) and antisera to mouse and 
human BM-40/osteonectin were generously supplied by Dr. R. Timpl. 
An antiserum to the transglutaminase cross-link was raised against a 
1. Abbreviation  used in this paper:  FPLC, fast protein liquid chromatog- 
raphy. 
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Figure 1.  Characterization of antibodies raised against the trans- 
glutaminase cross-link.  (A) The antigen,  [N,N-didansyl(3,-Glu-e- 
Lys)],hemocyanin, was coated to 96-weU plates (at 5/~g/ml) and 
detected  with  hemocyanin-adsorbed antiserum to  the  cross-link 
conjugate that had been preincubated with serial dilutions of',/-Glu- 
E-Lys  ([]; C, structural formula a), N,-acetyl-Lys (e;  C, b), Glu- 
~-ethylester (-; C, c) or Na-acetyl-Lys (+ ; C, d), and peroxidase- 
hemocyanin conjugate.  The ~-Glu-e-Lys  dipeptide  (50 mg;  Sigma)  was 
NH2-terminally blocked by dansylation in 9.6 mM sodium phosphate, pH 
7.4,  140 mM NaCI  (PBS),  using cyclohepta-amylose.dansylchloride  (10- 
fold molar excess) as described (Aeschlimann et al.,  1993)• The product 
was purified on a Bio-Gel P-2 column (Bio-Rad) in the same buffer (record- 
ing of absorbance at 335 rim) and coupled to Limulus polyphemus hemocya- 
nin (10 nag; Sigma) via its free carboxyl groups by a modified carbodiimide 
protocol  (Staros et al.,  1986). The protein conjugate was finally separated 
from low molecular mass compounds on a PD-10 column (Pharmacia LKB 
Nuclear,  Gaithersburg,  MD), equilibrated in PBS,  and used for antibody 
production in rabbits (250  /xg/injection) as described (Aeschlimann and 
Paulsson,  1991). The  antiserum was  adsorbed either with a  hemocya- 
nin-Sepharose  matrix  (Aeschlimann  and  Paulsson,  1991) or  with  a 
Sepharose  affinity matrix obtained by coupling  a N~-acetyl-Lys-hemocya- 
nin conjugate (obtained as described above) to remove contaminating  hemo- 
cyanin antibodies and antibodies cross-reactive  with N~-acetyl-Lys, respec- 
tively, and the specificity verified in an inhibition-style ELISA (Fig.  1). 
Histochemical Methods 
Tissues were frozen on dry ice in Tissue-Tel~ (Miles, Inc., Naperville, IL). 
For immunohistochemistry,  5-t~m sections were cut, adsorbed to gelatin- 
coated slides,  air dried, and immunolabeled with the indicated  antibodies 
using the peroxidase protocol as previously described (Aeschlimann et al., 
1993). To increase  antibody penetration, sections were demineralized in 
TBS (50 mM Tris-HCl, pH 7.4, 0.15 M NaCI) containing 0.42 M EDTA 
and digested for 1 h with 40 mU/nd chondroitinase ABC (Seikagaku Corp., 
Tokyo, Japan) in 0.1 M Tris-HCl, 0.1 M sodium acetate, pH 7.4, containing 
0.01% (wt/vol) bovine serum albumin, where indicated.  Calcification of tis- 
sues was visualized by yon Kossa's stain for calcium phosphate (Schenk et 
al.,  1984). For autoradiography,  sections  were exposed  to Kodak NTB-2 
liquid emulsion. 
Protein Extraction from Tracheal Cartilage 
Tracheal cartilage was dissected  from adhering soft tissue and, when ob- 
tained from explant cultures,  briefly homogenized  in 10 ml/g wet tissue of 
4 M guanidine HCI, 50 mM Tris-HCl, pH 6.0, containing 0.1 M EDTA and 
the protease inhibitors N-ethylmaleimide  (1 mM NEM),  PMSF (1 mM), 
benzamidine (10 mM), and 6-aminohexanoic  acid (0.1 M), and extracted 
by stirring for 2 h at room temperature.  Directly  isolated cartilage was se- 
quentially extracted by homogenization in 13 ml/g wet tissue of (a) ice-cold 
50 mM Tris-HCl, pH 7.4, containing 0.15 M NaCI and the protease inhibi- 
tors, and by stirring for 2 h at 4°C in b the same buffer containing in addition 
0.42 M EDTA and in c 4 M guanidine HCI, 50 mM Tris-HCl, pH 7.4, con- 
taining 0.42 M EDTA and the protease  inhibitors. The homogenates were 
centrifuged at 35,000 g for 20 min, and extracted proteins precipitated from 
the supernatants  with ice-cold ethanol (1:9 vol/vol).  The precipitates were 
collected by centrifugation and resuspended by boiling in SDS-PAGE sam- 
ple mixture containing 4 M urea• 
Digestion of cartilage  from cultured tracheal explants  was performed 
with 20 mg ot-chymotrypsin (bovine pancreas,  45 U/mg; Serva Biochemi- 
cals, Paramus,  NJ)/g wet tissue in 50 mM Tris-HCl, pH 7.4, 0.15 M NaCI, 
0.1 M EDTA, and 10 mM NEM for 48 h at room temperature while shaking. 
The digestion was stopped by addition of a concentrated  stock solution to 
yield the same 4 M guanidine HCI-extraction  buffer as above, in this in- 
stance containing 10 mM PMSF,  and the tissue extracted  as above. 
conjugated  secondary  antibodies.  (Other compounds  tested  and 
found to be noninhibitory include N~-acetyl-Gln, N~-carbobenz- 
oxy-Gln-Gly,  Lys,  and  Na-acetyl-Lys-methylester).  The  residual 
reactivity of the adsorbed antiserum is directed mainly to the dansyl 
group, a synthetic compound that has no structural analogue in bio- 
logical systems. The results are shown as a mean of two determina- 
tions. (B) The antiserum was adsorbed with a  Sepharose affinity 
matrix made  from a  N,-acetyl-Lys-hemocyanln conjugate to  re- 
move antibodies cross-reactive with N,-acetyl-Lys and was subse- 
quently tested as  above (El, "y-Glu-e-Lys;  e,  N~-acetyl-Lys).  (C) 
Structural formulas of the various inhibitors are represented, with 
parts  differing  from  the  transglutaminase  cross-link  structure 
printed in italics. 
Aeschlimann et al.  Transglutaminase Cross-linking in Cartilage Matrix  883 Transglutaminase Assay 
In vitro cross-linking  of recombinant  BM-40/osteonectin  and incorporation 
of monodansylcadaverine into  N,N-dimethylcasein (Serva) with tissue 
transglutaminase was done as  described previously (Aeschlimann and 
Paulsson, 1991). 
SDS-PAGE and lmmunoblotting 
SDS-PAGE (Laemmli, 1970) was done in 4-20%  gradient gels. Proteins 
were reduced with 2-mercaptoethanoi (1% vol/vol) when desired, and de- 
tected by staining with Coomassie brilliant blue R or immunocbemically 
after transfer onto nitrocellulose (Towbin et al.,  1979). Binding of primary 
antibody was visualized  using peroxidase-conjugated  swine anti-rabbit IgG 
(Dakopatts, Glostrup, Denmark) and the ECL kit (Amersham) according 
to the manufacturer's  protocol. Stripping and reprobing of membranes was 
done as described (ECL kit). When using the antibodies to the trans- 
glutaminase cross-link, nonspecific  binding was blocked with bovine serum 
albumin, which had been shown not to be a transglutaminase substrate 
(Aeschlimann  and Paulsson, 1991) and does therefore  not contain cross-link 
epitopes, and binding of primary antibodies was detected with 35S-labeled 
donkey anti-rabbit IgG (Amersham). 
Results 
Characterization  of the Antibodies to the 
Transglutaminase  Cross-link 
To demonstrate  transglutaminase  cross-linking  in  vivo we 
raised  polyclonal  antibodies  against  the  unique  reaction 
product  of these  enzymes,  the  3,-Glu-e-Lys dipeptide.  For 
this purpose the dipeptide was coupled to hemocyanin after 
blockage of amino groups by dansylation ([N,N-didansyl(3,- 
Glu-~-Lys)]ohemocyanin).  The  antiserum  was  purified  by 
adsorption to a hemocyanin-Sepharose matrix and the spec- 
ificity of the remaining antibodies was tested in an inhibition- 
style ELISA (Fig.  1 A).  Among the structural  analogues to 
the antigen tested, only -/-Glu-e-Lys and N,-acetyl-Lys were 
able to inhibit antibody binding at concentrations  below 20 
mM (3,-Glu-E-Lys gave half-maximal inhibition at ,x,10/~M, 
N,-acetyl-Lys  at  three-  to  fourfold  higher  concentration). 
The reactivity of the antibodies  with N,-acetyl-Lys was ex- 
pected as the compound is structurally identical to "g-Glu-e- 
Lys but smaller (Fig,  1 C).  The maximum inhibition  with 
N,-acetyl-Lys  is  lower,  indicating  that  a  subpopulation 
(~22%)  of the antibodies  recognizing  the ,y-Glu-~-Lys di- 
peptide  is  completely  specific  for  the  cross-link.  This 
antibody  population  was  further  purified  by adsorption  of 
the  antiserum  to  a  N,-acetyl-Lys-hemocyanin-Sepharose 
matrix,  giving a  fraction  of antibodies  that  is inhibited  by 
N,-acetyl-Lys  only  at  >l,000-fold  higher  concentrations 
than  of ~-Glu-E-Lys  (Fig.  1  B).  N~-acetylation  of lysines 
occurs  physiologically  in  nuclear  proteins  (Turner,  1991) 
while  transglutaminase  cross-linking  has  been  reported 
in the cytosol, at the plasma membrane, and in the extracel- 
lular  space  (Aeschlimann  and  Paulsson,  1994).  The com- 
partmentalization  of the respective reactions as well as the 
removal  of cross-reactive  antibodies  allows  discrimination 
between these structures. 
To further demonstrate the specificity of the antibodies, we 
performed immunostaining on skin and immunoblotting on 
in vitro cross-linked proteins (Fig. 2). The massive intracel- 
lular cross-linking by epidermal transglutaminases in termi- 
nal differentiation of keratinocytes leads to the formation of 
the cornified  envelopes  (Thacher  and  Rice,  1985;  Hohl et 
al.,  1991;  Kim  et  al.,  1993;  Aeschlimann  and  Paulsson, 
1994).  Immunostaining  with  the  novel antibodies  revealed 
increasing  levels of cross-linking  in  the upper spinous  and 
granular  layers  of epidermis  and  in  the  stratum  corneum 
(Fig.  2 A). This staining agrees with the expression pattern 
of keratinocyte transglutaminase (Thacher and Rice,  1985). 
Intense staining for the cross-link is also observed in the in- 
Figure 2. Detection of the transglutaminase cross-link on sections of skin and of in vitro cross-linked proteins by immunoblotting. 5-#m 
cryosections of rat paw skin (A and B) were incubated with antibodies specific to the transglutaminase cross-link (A; compare Fig.  1 B) 
or nonimmune serum (B),  and developed using peroxidase-conjugated secondary antibodies.  Tissue structures in skin are indicated as 
follows:  basement membrane (BM), separating dermis (D), and epidermis (spinous layer [SS], granular layer [SG] and stratum corneum 
[SC]).  Bar,  50 tzm. (C) Human recombinant osteonectin was incubated with guinea pig liver tissue transglutaminase in the presefice of 
lysine (1 mM) and either 25 mM EDTA (lane 1 ) or 5 mM Ca  2+ (lane 2) for 30 min at 37°C.  The reaction mixture was subjected to SDS- 
PAGE under reducing conditions,  then proteins were transferred to a nitrocellulose membrane and epitopes generated by the action of 
the Ca2+-dependent  transglutaminase were detected with the antibodies to the cross-link and 35S-labeled secondary antibodies.  The pro- 
tein bands assigned to osteonectin (ON), osteonectin oligomers (9OK, 135K, 175K; compare Fig.  9), and tissue transglutaminase (tTG) 
are indicated  on the right. 
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tent  with  the  function of epidermal  transglutaminase in 
cornification of this tissue (Kim et al.,  1993;  Lee et al., 
1993).  In addition,  transglutaminase cross-linking is  ob- 
served  in  the basement membrane  underlying epidermis 
(Fig. 2 A) and surrounding hair follicles (results not shown), 
presumably due to tissue transglutaminase (Lichti et al., 
1985)  catalyzed cross-linking of e.g.,  nidogen and  BM- 
40/osteonectin (Aeschlimann and Paulsson, 1991; Aeschli- 
mann et al., 1992). Incorporation of lysine into recombinant 
BM-40/osteonectin  by  tissue  transglutaminase  generated 
epitopes that are reactive with the antibodies to the cross- 
link (Fig. 2 C). The generation of such epitopes also in tissue 
transglutaminase is due to the autocatalytic activity of the 
enzyme (Aeschlimann and Paulsson,  1991). 
Detection of the Transglutaminase Cross-link in 
Differentiating Cartilages 
Transglutaminase cross-links were revealed in the mineral- 
ized matrix of  the hypertrophic zone of growth plate cartilage 
and in bone matrix of developing rat long bones by antibody 
labeling after decalcification of the tissue and digestion of 
glycosaminoglycans with chondroitinase ABC (Fig.  3 B). 
Preincubation of sections with Ca2÷-containing buffer gave 
labeling of also not digested and demineralized tissue, re- 
flecting the activation of the intracellular pool of transglu- 
taminase in the earlier chondrocyte maturation steps (Fig. 3 
D; large arrow) and in osteoblasts (Fig. 3 D; e.g., along the 
bone trabeculae). Control sections preincubated with EDTA- 
containing buffer were negative (similar to Fig. 3 A). This 
pattern of cross-linking in epiphyseal growth plate cartilage 
correlates with the distribution of tissue transglutaminase 
protein (Aeschlimann et al., 1993). The enzyme responsible 
for cross-linking of bone matrix is likely to be a different 
member of the transglutaminase protein  family (Aeschli- 
mann et al.,  1993).  Transglutaminase cross-linking in the 
matrix of growth plate cartilage (Fig. 3 B, small arrow) oc- 
curs in parallel with the deposition of osteonectin (Fig. 3 E) 
and matrix mineralization (Fig. 3  C). 
In maturing tracheal cartilage, the transglutaminase cross- 
link was detected around the  calcium phosphate  mineral 
deposits  in the center  of the horseshoe-shaped cartilages 
(Fig. 3 F; compare with Fig. 6 C, inset), which is in agree- 
ment with the expression of tissue transglutaminase (Aesch- 
limann et al.,  1993).  Foci of intense staining (arrowhead) 
appear to be  single hypertrophic chondrocytes which are 
cross-linked intracellularly and/or in the pericellular matrix, 
Figure 3. Detection of the transglutaminase cross-link on sections 
of developing long bone and maturing tracheal cartilage. 5-#m 
cryosections of a newborn rat tarsal bone (A-E) and of a 9-wk-old 
rat tracheal cartilage (F and G) were incubated with antibodies 
specific to the transglutarninase cross-link (B, D, and F; compare 
Fig. 1 B), to osteonectin (E and G) or with nonspecific  serum (A). 
Binding of primary antibodies was visualized using peroxidase- 
conjugated secondary antibodies. Sections A, B, E, F, and G were 
postfixed with  methanol,  decalcified and  digested with  chon- 
droitinase ABC before immunolabeling,  while section D was prein- 
cubated with Ca~+-containing  buffer (Aesehlimann et al., 1993). 
Mineralization was revealed by yon Kossa's  stain for calcium phos- 
phate  (C).  Histologically discernible zones in long bones are 
marked (A). E, epiphysis; M, metaphysis; and D, diaphysis. Bars, 
50 #m. 
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cross-linking.  Also  the  staining  for  immunoreactive os- 
teonectin in the periphery of  the mineralized area occurs fre- 
quently in foci (Fig. 3 G, arrowhead). The absence of stain- 
ing for the cross-link in the fully mineralized matrix could 
be due to limited penetration of the antibodies even after" 
decalcification and chondroitinase digestion. 
Characterization  of the Cartilage Culture System Used 
to Detect Transglutaminase  Activity In Situ 
To determine the physiological role of  cartilage matrix cross- 
linking by transglutaminases, we developed an organ culture 
system for  tracheal  cartilage  which  allowed us  to  detect 
transglutaminase  activity  and  target  proteins  for  cross- 
linking  in  situ.  We  used  the  synthetic  amine  substrate 
monodansylcadaverine, previously used in other culture sys- 
tems (Cornwell et al.,  1983; Kvedar et al.,  1992) to detect 
transglutaminase activity and synthesized an inactive deriva- 
tive, dansylamidopentanol (Fig.  4 A) for use as a control. 
(The toxic concentration reported for dansyl compounds, 
i.e.,  monodansylcadaverine, in  cell  culture  is  •0.2  mM 
[Cornwell et al.,  1983].  We observed detachment of cells 
from the substratum at those concentrations of monodansyl- 
cadaverine and dansylamidopentanol with cultured  A204 
human rhabdomyosarcoma cells [J.-P. Kleman, D. Aeschli- 
mann, M. Paulsson, and M. van der Rest, manuscript sub- 
mitted for publication], but we observed good viability at up 
to ,x,1 mM in tracheal explant culture. This higher tolerance 
is consistent with results obtained with skin explants [Kvedar 
et al.,  1992] and might be explained by a diffusion gradient 
across the explants. We obtained identical results when using 
N 
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Figure 4. Tissue transglutaminase-catalyzed  protein cross-linking 
in presence of monodansylcadaverine  (dansylamidopentylamine) 
(A-C, I) or dansylamidopentanol (A-C, //).  The structural for- 
mulas of  the dansyl compounds  are given in A. Guinea pig liver tis- 
sue transglutaminase  was incubated  with N,N-dimethylcasein  at pH 
7.0 in presence of either compound for 30 rain at 37°C, the reaction 
mixture separated by SDS-PAGE and the proteins stained with 
Coomassie  blue (B) or after transfer to nitrocellulose  by incubation 
with anti-dansyl  antiserum (C). Mr standards and the top and bot- 
tom of  the separating gel (arrows) are indicated on the left, the pro- 
tein bands assigned to N,N-dimethylcasein  (CAS) and tissue trans- 
glutaminase (tTG) on the right. 
0.1 and 0.5 mM monodansylcadaverine  and 0.5 mM monobi- 
otincadaverine [Lee et al.,  1992] in our experiments.) We 
verified the validity of dansylamidopentanol as a control by 
incubation of tissue transglutaminase with the glutaminyl 
substrate protein N,N-dimethylcasein and either monodan- 
sylcadaverine or dansylamidopentanol at various pH values 
(from 5 to 9). The reactions gave incorporation of the amine, 
but not the alcohol (Fig.  4, B and C). Potential toxicity of 
the dansyl compounds at the concentrations used in culture 
(0.1 or 0.5 mM) could be excluded as metabolic labeling of 
the cultures  with [3sS]methionine  after treatment with ei- 
ther compound and quantitation of protein-bound radioac- 
tivity gave identical values as control cultures (results not 
shown; see also Fig. 7). 
Transglutaminase  Activity Is Associated with 
Hypertrophic  Chondrocytes  in the Mineralizing Areas 
of Cultured Tracheae 
Tracheae  of young  adult  rats  were  incubated  in  culture 
for 24 h  with the transglutaminase substrate monodansyl- 
cadaverine or the substrate analogue dansylamidopentanol 
and chased in medium without label. Immunohistochemical 
detection of  the dansyl group revealed that label was incorpo- 
rated in tissue incubated with the amine substrate, but not 
with the control derivative (Fig. 5, A and B). Staining was 
predominantly present in a  ring around the chondrocytes, 
probably due to cross-linking of the dansyl label to proteins 
of the pericellular matrix and/or deposited at the intracellu- 
lar face of the plasma membrane (Fig. 5 C). The labeling 
intensity increased with chondrocyte maturation (Fig. 5 C) 
which proceeds towards the center of the tracheal cartilages 
where the tissue undergoes mineralization (Fig. 6).  Trans- 
glutaminase activity is highest in the layer of hypertrophic 
chondrocytes surrounding the mineral deposits (Fig. 5 C). 
This activity pattern is consistent with the previously ob- 
served expression of tissue transglutaminase on the protein 
level (Aeschlimann et al.,  199.3). Indeed, staining of serial 
sections for immunoreactive tissue transglutaminase and for 
incorporated monodansylcadaverine revealed coinciding pat- 
terns (results not shown). 
To determine the onset of transglutaminase activity during 
tracheal cartilage development we studied explants taken at 
different time points in the rat postnatal growth phase. In ex- 
plants from newborn rats, transglutaminase activity could 
not be detected (results not shown), consistent with the pre- 
viously observed absence of tissue transglutaminase protein 
at this stage in vivo (Aeschlimarm et al., 1993).  In explants 
from 4-5-wk-old  rats,  the first cells expressing transglu- 
taminase activity were detectable in the center of a few tra- 
cheal cartilages, whereas in those from 6-7-wk-old  rats, en- 
zyme activity was prominent in the hypertrophic zone of all 
horseshoe-shaped cartilages (Fig.  6, A and B). Mineraliza- 
tion started around week 7, corresponding to the age of pu- 
berty (Fig.  6  B).  Expression of transglutaminase activity 
preceded the onset of mineralization, in agreement with the 
pattern seen in mature cartilage where enzyme activity is 
highest in the layer of hypertrophic chondrocytes adjacent to 
mineral deposits (Fig.  5  C).  The occurrence of both pro- 
cesses in rapid succession in the postnatal development indi- 
cates that expression of active transglutaminase and mineral- 
ization  may be  coupled.  Explants  from animals  of eight 
weeks or older resemble the situation in adult animals where 
The Journal of Cell Biology, Volume 129,  1995  886 Figure 5. Detection of incorporated monodansylcadaverine on sections of tracheae after in sial labeling. Adult rat (•3  mo) tracheae were 
cultured for 24 h in the presence of  0.5 mM of either the transglutaminase substrate monodansylcadaverine  (A and C) or the control deriva- 
tive dansylamidopentanol (B) and chased in medium without label. The tissue was cryosectioned (5/zm), incubated with anti-dansyl antise- 
rum, developed with peroxidase-conjugated secondary antibodies (3-amino-9-ethylcarbazole/H202  used as peroxidase substrate solution: 
brown stain) and counterstained with Mayers H~rnalaun (blue stain). The calcified area in C is indicated by arrows. Bars, 50 ttrn. 
transglutaminase activity is observed in the hypertrophied 
and calcified areas of the horseshoe-shaped cartilages, but is 
absent from resting cartilage (Fig. 6  C). 
The apparent activation of the transglutaminase in the late 
stages of chondrocyte differentiation led us to examine the 
viability of the cells in the terminal differentiation program 
as externalization and/or intracellular activation of the trans- 
glutaminase might occur by cell death in combination with 
membrane disintegration and leakage of intracellular com- 
ponents or a rise in intracellular [Ca2÷], respectively. Meta- 
bolic labeling of the cultures with [3sS]methionine,  followed 
by autoradiography of tissue sections demonstrated that all 
chondrocytes were metabolically active (Fig. 7). No signs of 
cell death were seen in any stage of chondrocyte differentia- 
tion, and even cells fully embedded in a calcified matrix were 
active in protein synthesis (Fig. 7 C, arrowhead). Thus, the 
abundance of transglutaminase activity associated with all 
maturing chondrocytes is clearly not due to cell death. 
Substrate Proteins of the Endogenous 
Transglutaminase in Tracheal Cartilage 
Tracheal explants were labeled in culture and dissected car- 
tilages extracted with 4 M guanidine HC1 in the presence of 
inhibitors of transglutaminases (EDTA, N-ethylmaleimide) 
and proteases.  SDS-PAGE and immunoblotting with anti- 
dansyl antibodies revealed covalent attachment of the dansyl 
compound to proteins from explants incubated with mono- 
dansylcadaverine (Fig.  8, lanes a  and c), but not from ex- 
plants  incubated  with  dansylamidopentanol  (results  not 
shown). Most of the dansyl label was detected in high molec- 
ular mass proteins or protein complexes, but a  prominent 
glutaminyl  substrate  protein  with  an  apparent  molecular 
mass of ,o38 kD without and •43  kD with prior reduction 
can be clearly distinguished (Fig. 8, lanes a and c). The char- 
acteristic shift in mobility of this labeled protein following 
reduction resembles the behavior of  osteonectin. Indeed, im- 
munoblots of the tracheal extract probed with antibodies to 
the dansyl moiety (Fig. 8, lanes a  and c) and to osteonectin 
(Fig. 8, lanes b and d) reveal comigration of these proteins, 
supporting the identity of the dansyl-labeled protein with os- 
teonectin. Osteonectin with dansyl label attached migrated 
slightly slower upon reduction than osteonectin without the 
modification, resulting in a doublet-band (Fig. 8, lanes c and 
d; compare Fig. 9, lane h). 
Extensive digestion of tracheae, labeled with monodansyl- 
cadaverine in culture, with ct-chymotrypsin  before extraction 
and immunoblotting with anti-dansyl antiserum, resulted in 
disappearance of the labeled high molecular mass proteins 
or protein complexes while fragments of an apparent molec- 
ular mass  of ,o55,  60,  and  100 kD were stable to further 
cleavage (Fig. 8, lane e). The ,,ol00-kD component was by 
immunoblotting shown to represent type II collagen (Fig. 8, 
lane f). 
The demonstration of cross-linking of the dansyl label to 
extracellular matrix proteins, i.e., osteonectin and collagen 
II (Fig.  8), shows that at least part of the transglutaminase 
activity associated with hypertrophic chondrocytes (Fig. 5) 
is present in the pericellular matrix. We cannot exclude that 
intracellular  cross-linking  does  also  occur,  although  the 
present  results  are  in  full  agreement  with  an  extracellu- 
lar cross-linking.  This  supports  the  previous immunohis- 
tochemical observation of an intracellular accumulation of 
tissue  transglutaminase  in  the  early steps  of chondrocyte 
differentiation and its subsequent externalization before min- 
eralization of the tissue (Aeschlimann et al., 1993). The un- 
masking of 3,-glutamyl-e-lysine cross-links in cartilage upon 
digestion with chondroitinase ABC (Fig. 3) is also consistent 
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cartilage during the rat postnatal growth phase. 
Tracheal explants from 4- (A), 6- (B), and 8- (C) 
wk-old rats were incubated in culture with 0.5 
mM monodansylcadaverine  for 24 h and chased 
in medium without label. The tissue was cryo- 
sectioned (5 #m)  and incorporated label de- 
tected with anti-dansyl antiserum and peroxi- 
dase-conjugated secondary antibodies. Calcium 
phosphate-containing  mineral  deposits  were 
visualized  by von Kossa's stain for calcium phos- 
phate, shown in the insets. Not all cartilages are 
at exactly the same developmental stage at a 
given time point as exemplified  by the differing 
extent of mineralization in  two  neighboring 
cartilages in panel R  Monodansylcadaverine 
incorporation is shown for a cartilage that has 
not yet become mineralized. Bar, 50 #m. 
with  extraceUular  transglutaminase  activity.  Indeed,  im- 
munohistochemical detection of extracellular matrix pro- 
teins  in  cartilage,  e.g.,  cartilage  proteoglycan  aggregate 
(Poole et al.,  1982)  or fibronectin (Mackie et al.,  1987), 
does often reveal predominant staining in the chondrocyte 
pericellular matrix, presumably due to masking of the pro- 
teins  in  the mature matrix.  Further,  incorporation of the 
transglntaminase into the matrix may lead to its inactivation 
as indicated by e.g., the presence of tissue transglutaminase 
antigen in the cartilage cores of bone trabeculae but lack of 
transglutaminase activity in this location (Aeschlimann et 
al.,  1993). Pulse-labeling with monodansylcadaverine (Fig. 
5) might reveal only the active enzyme in the newly depos- 
ited  matrix.  The  demonstration  of metabolic  activity  in 
chondrocytes expressing high levels of transglutaminase ac- 
tivity (Fig.  7) indicates that externalization of tissue trans- 
glutaminase must occur by a mechanism other than cellular 
disintegration. 
Osteonectin Is Present in Cross-linked Complexes in 
Skeletal Tissues In Vivo 
Adult rat tracheal cartilage was sequentially extracted with 
buffered saline, saline supplemented with EDTA, and a 4 M 
guanidine HC1/EDTA solution in presence of inhibitors of 
transglutaminases and proteases. SDS-PAGE and immuno- 
blotting with antibodies to osteonectin revealed several im- 
munoreactive bands of higher apparent molecular mass than 
the monomeric protein (Fig. 9). Bands of ,065, 90, and 175 
kD were resistant to reduction, even after boiling in urea and 
SDS (Fig. 9, lanes a-c).  To exclude a contaminating reac- 
tivity in our antiserum to rat bone osteonectin we verified 
this result with an antiserum raised against the mouse En- 
gelbreth-Holm-Swarm tumor-derived protein  (results  not 
shown). Presumably, these bands represent covalenfly stabi- 
lized protein complexes with osteonectin as a constituent. In 
vitro cross-linking of  recombinant BM-40/osteonectin by tis- 
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from  cultured tracheae following meta- 
bolic  labeling  with  [3sS]methionine. 
Tracheae of  4- (A), 6- (B), and 8- (C) wk- 
old rats were cultured in the presence of 
0.5  mM  monodansylcadaverine,  subse- 
quently  pulse-labeled with  [35S]methio- 
nine for 24 h and chased in medium with- 
out label. 5-/~m cryosections of the tissue 
were covered with photographic emulsion 
and exposed for 2  d.  The photographic 
reaction was developed (black grains) and 
the  tissue  weakly  counterstained  with 
Mayers H~'nalann.  The darker staining 
(Hiimalann)  area  in  the  center  of  the 
horseshoe-shaped cartilage in C indicates 
cartilage calcification. Bar, 50/~m. 
Figure  8.  Analysis of trans- 
glutaminase  substrate  pro- 
teins in tracheal cartilage after 
in situ labeling  with monodan- 
syleadaverine. Tracheae were 
cultured for 24 h in the pres- 
ence of 0.5 mM monodansyl- 
cadaverine  and  chased  in 
medium  without  label.  The 
proteins were  extracted with 
4  M  guanidine HC1  contain- 
ing buffer (in the presence of 
transglutaminase  inhibitors), 
either directly (lanes a-d)  or 
after extensive digestion of the 
tissue  with  ¢~-chymotrypsin 
(lanes e and f), and separated 
in  4-20%  SDS-polyaeryl- 
amide gels without (-SH) or 
with (+SH)  prior reduction. 
Proteins  were  detected  after 
transfer  to  nitrocellulose by 
incubation with antibodies to 
the dansyl moiety (lanes a, c, and e), to osteonectin (lanes b and d) or to collagen type II (lane  f) by stripping and reprobing the membranes. 
M, standards as well as top and bottom of the separating gels (arrows) are indicated on the left. The protein bands assigned to osteonectin 
and collagen type II are marked with the label ON and Col 1I, respectively. 
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osteonectin  and  osteonectin 
complexes present in cartilage 
and  bone.  Proteins  sequen- 
tially extracted from adult rat 
tracheal  cartilage  with  buf- 
ered saline (lane a), contain- 
ing EDTA (lane b) and guani- 
dine HCI/EDTA  (lane c), were 
separated by SDS-PAGE per- 
formed under  reducing con- 
ditions  and  after  transfer  to 
nitrocellulose stained by incu- 
bation with antibodies to os- 
teonectin (lanes a-c).  Osteo- 
nectin prepared from rat long bone was revealed by Coomassie blue staining after SDS-PAGE separation and transfer to polyvinylidene 
difluoride membrane (lane d). Human recombinant osteonectin was incubated with guinea pig liver tissue transglutaminase in presence 
of 25 mM EDTA (lane e), 5 mM Ca  2÷ (lanesfand g), or 5 mM Ca  2÷ and 20/~M monodansylcadaverine (lane h) for 30 min (lanes e, 
f, and h) or 2 h (lane g) at 37°C and the proteins were subsequently separated by SDS-PAGE  and detected after transfer to nitrocellulose 
with antibodies to osteonectin. Mr standards as well as top and bottom of the separating gels (arrows)  are indicated on the left. The 
protein bands assigned to osteonectin (ON), osteonectin-monodansylcadaverine complex (ON*), osteonectin oligomers (9OK, 135K, and 
175K) and a 65-kD osteonectin complex (65K) are indicated on the right. 
sue transglutaminase yields products which resemble the 90- 
and  175-kD osteonectin complexes isolated from cartilage, 
indicating that these complexes represent osteonectin dimers 
and tetramers, respectively (Fig. 9, lanes e-g). Furthermore, 
incorporation  of monodansylcadaverine into  recombinant 
BM-40/osteonectin results in a slightly retarded migration of 
the protein in SDS-PAGE (Fig.  9,  lane h), resembling the 
pattern  observed in  the  cartilage explant cultures  with  a 
doublet-band  in  the  monomer  position  (compare  Fig.  8, 
lanes  c  and d).  A  pattern of osteonectin-immunoreactive 
bands similar to that in tracheal cartilage extracts was ob- 
tained in extracts from long bones and purification of os- 
teonectin from this source revealed, in addition to the mono- 
meric protein, a copurifying complex of ",~65 kD that was 
reactive with the antibodies to osteonectin (Fig. 9, lane d). 
NH2-terminal  sequencing of the two bands  with  apparent 
molecular masses of 40 and 43 kD in the monomer position 
(Fig. 9, lane d) gave both the sequence APQTEAAEEM that 
is closely similar to APQQTEVAEEI previously determined 
for  mouse  osteonectin  (Mason  et  al.,  1986),  confirming 
them  to  be the  rat osteonectin homologue.  The  ,'~65-kD 
complex gave APQT, representing the NH2 terminus of os- 
teonectin, and GA(hydroxyP)GP, originating from a colla- 
gen. The collagen sequence was too short to be unambigu- 
ously assigned to the subtype. It remains however unclear if 
the complex represents osteonectin covalently bound to an- 
other component,  e.g.,  a  collagen  fragment,  or  only os- 
teonectin, i.e., a degradation product of an oligomer. 
Discussion 
Amine incorporation in cultured tracheal explants revealed 
that  in cartilage of adult rats,  transglutaminase activity is 
predominantly associated with the chondrocytes surround- 
ing the calcium phosphate deposits,  which phenotypically 
resemble the hypertrophic chondrocytes of long bone growth 
plate.  During the postnatal development of trachea, trans- 
glutaminase activity could first be detected around chondro- 
cytes shortly before the onset of mineralization. This finding 
is consistent with the previously observed intracellular ac- 
cumulation and subsequent externalization of tissue trans- 
glutaminase  protein  by  chondrocytes in  the  hypertrophic 
zone of long bone growth plate and trachea in vivo (Aesch- 
limann et al.,  1993). Indeed, detection of the unique trans- 
glutaminase reaction product, the 7-glutamyl-e-lysine cross- 
link, with a specific antibody on tissue sections revealed the 
cross-link  in  the  hypertrophic cartilage of the  epiphyseal 
growth plate and the mineralizing area of  tracheal cartilages, 
but not in resting cartilage. The demonstration of amine in- 
corporation  into  matrix  proteins  in  cultured  tracheal  ex- 
plants (Fig.  8) together with the detection of incorporated 
amine around differentiating chondrocytes (Fig. 5) suggests 
that the cross-linking occurs predominantly in the pericellu- 
lar matrix. The detection of 7-glutamine-e-lysine cross-links 
(Fig. 3) and tissue transglutaminase antigen (Aeschlimann et 
al.,  1993) in cartilage matrix and the requirement for depo- 
lymerization of glycosaminoglycan chains to unmask these 
epitopes  are  consistent  with  extracellular  cross-linking. 
These results  indicate that tissue transglutaminase expres- 
sion, externalization and activation, and mineral formation 
are consecutive steps in the chondrocyte  maturation program 
both during postnatal development of tracheal cartilage and 
in endochondral ossification. There is not necessarily a di- 
rect causal connection between these processes, even though 
transglutaminase-catalyzed cross-linking of the matrix could 
indeed alter its structure in a way that predisposes the tissue 
to calcification. Clustering of fixed charged groups by cross- 
linking of  anionic matrix proteins, e.g., to the collagen fibril, 
might provide a surface which promotes nucleation and/or 
growth of hydroxyapatite crystals (Boskey, 1992). Osteonec- 
tin and osteopontin are present in mineralizing areas of carti- 
lage and bone (Mets/iranta et al.,  1989;  Aeschlimann et al., 
1993; Ikeda et al.,  1992; Denhardt and Gut, 1993), are an- 
ionic and  contain calcium-binding domains  (Engel et al., 
1987;  Maurer et al.,  1992; Denhardt and Gut,  1993), and 
are transglutaminase substrates (Prince et al., 1991; Aeschli- 
mann et al.,  1993; Sorensen et al.,  1994). 
A prerequisite for the function of tissue transglutaminase 
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lar  space.  It  is  unlikely  that  tissue  transglutaminase  is 
secreted by the conventional pathway as the enzyme has a cy- 
toplasmic localization and lacks the characteristic features of 
secretory proteins, such as a signal peptide, glycosylation, 
and disulfide bonding, even though potential sites for such 
modifications are present in the sequence (for review see 
Aeschlimann and Paulsson, 1994).  The present demonstra- 
tion of protein synthesis by chondrocytes also in the mineral- 
ized areas of tracheal cartilage is consistent with metabolic 
and proliferative activity of chondrocytes in the calcified ma- 
trix of long bones detected by incorporation of [35S]sulfate 
and pH]thymidine, respectively (Hunziker,  1992  and per- 
sonal communication), and shows that externalization of the 
transglutaminase in the mineralizing matrix is not due to cell 
death.  This  is  further  supported  by  the  fact that  DNA- 
fragmentation, which accompanies apoptotic cell death in 
most cases (F6sus et al., 1991), has not been observed in the 
growth plate cartilage of the developing chicken limb (V. 
Thomazy,  personal  communication).  In  contrast,  tissue 
transglutaminase expression in the interdigital segment of 
the limb correlates with DNA fragmentation and apoptosis. 
The fate of terminally differentiated chondrocytes remains 
uncertain (Gentili et al., 1993), but tissue transglutaminase 
externalization and activation should be considered as part 
of the differentiation program of chondrocytes, independent 
from potential cell death. 
Since we and others failed to demonstrate widespread cell 
death and lysis in terminally differentiated cartilage, we con- 
clude  that tissue  transglutaminase is  externalized by an- 
other, not yet characterized mechanism. It has recently been 
shown that another transglutaminase family member, pros- 
tate transglutaminase, though absent from endoplasmic re- 
ticulum and Golgi complex, is released in apocrine secretory 
vesicles from dorsal prostate and coagulating gland during 
copulation (Seitz et al., 1990).  Prostate transglutaminase is 
therefore likely to enter the vesicles directly from the cyto- 
plasm.  Membrane-bound vesicles with cytoplasm-derived 
contents shedded from the cell surface could similarly be re- 
sponsible for the externalization of tissue transglutaminase. 
So called matrix vesicles that are selectively enriched in cer- 
tain cytoplasmic proteins have been observed in many tis- 
sues, including cartilage (Hale and Wuthier, 1987). 
Tissue transglutaminase binds tightly to components of 
the pericellular matrix upon release (Upchurch et al., 1991) 
and probably acts by cross-linking the surrounding matrix 
upon activation at the elevated Ca  2÷ concentration met in 
the extracellular space.  Fibrinogen and fibronectin bind to 
the surface of hepatocytes and endothelial cells in suspension 
culture and become cross-linked into the pericellular matrix 
by tissue transglutaminase (Barsigian et al.,  1991). Extrac- 
tion of the tracheal cartilage after labeling with monodansyl- 
cadaverine in culture revealed a distinct set of labeled pro- 
teins. Among these, osteonectin and type II collagen were 
identified as predominantly labeled components. This find- 
ing is consistent with the previously observed amine incor- 
poration into osteonectin and type II collagen in the transglu- 
taminase-catalyzed reaction in vitro (Aeschlimann et al., 
1993) but, in addition, demonstrates that these proteins are 
physiological substrates for the transglutaminase. Moreover, 
a previously described ,,~43-kD protein that acts as glutaminyl 
substrate for endogenous transglutaminase in homogenates 
of bovine epiphyseal growth plate cartilage (Aeschlimann et 
al.,  1993) appears to be osteonectin based on its elution in 
anion exchange and molecular sieve chromatography and on 
its immunological similarity (results not shown). Extraction 
of adult rat tracheal cartilage revealed, in addition to os- 
teonectin monomer, high molecular mass complexes that 
were  resistant  to  reduction  and  immunoreactive  for  os- 
teonectin. The complexes with an apparent molecular mass 
of 90 and 175 kD probably represent cross-linked osteonec- 
tin oligomers since  similar complexes were formed upon 
cross-linking of osteonectin by tissue transglutaminase in 
vitro. In contrast, a major 65-kD complex gave the NH2- 
terminal sequence of osteonectin by Edman degradation, but 
was not formed by in vitro cross-linking. It is possible that 
the 65-kD complex results from cross-linking of osteonectin 
with another component, but the amounts of sample avail- 
able did not allow an unambiguous identification of such a 
component. 
The proteins cross-linked to osteonectin in situ need to be 
further  characterized  and  the  sequence  locations  of the 
cross-linking sites identified. Once available,  this informa- 
tion will provide an insight into the physiological interaction 
partners of osteonectin and into the organization of the cal- 
cifying matrix. Osteonectin may bind to collagens (Sage et 
al.,  1989;  Mayer et al., 1991) and influence calcium phos- 
phate deposition in the mineralization process in cartilage 
and bone (Termine et al., 1981b; Engel et al., 1987; Maurer 
et  al.,  1992).  The  present  demonstration  of  the  trans- 
glutaminase cross-link in bone matrix, the isolation of cross- 
linked osteonectin complexes from long bones and the previ- 
ously  reported  presence  of transglutarninase  activity  in 
newly deposited osteoid (Aeschlimann et al., 1993) indicate 
a  more  general  role  for  transglutaminase  cross-linking 
in  skeletal tissues,  even though the enzymes involved in 
bone and cartilage may be different members of the trans- 
glutaminase protein family (Aeschlimann et al., 1993). Dif- 
ferential posttranslational modification (Kelm and Mann, 
1991) may serve to regulate the diverse biological functions 
proposed for osteonectin in different tissues (Clezardin et 
al., 1988; Mayer et al., 1991; Sage and Bornstein, 1991) and 
transglutaminase cross-linking may indeed alter the proper- 
ties of the protein either by amine incorporation or formation 
of protein complexes. 
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